Elite business, honest price.
Hyperliquid is the best business in on-chain trading and one of the only tokens where the profits actually come back to holders. It keeps 100% of trading fees and spends almost all of them buying HYPE. The catch is that revenue is shrinking, the price sits near its all-time high, and roughly three quarters of the supply has not reached the market yet. A great company, not a cheap entry.
What it actually is
Hyperliquid is a decentralized exchange for perpetual futures that runs on its own blockchain. Traders use it because it feels as fast and deep as a big centralized venue, but they keep custody of their own money. It is the clear leader: 60 to 70 cents of every dollar of on-chain perp trading happens here. The business model is the simple kind. It charges trading fees, about $850M a year annualized, and it keeps all of them. There is no distribution partner skimming the economics and no supply-side leakage to validators.
The value accrual is what separates it from almost everything else in crypto. Roughly 97 to 99 cents of every fee dollar flows into the Assistance Fund, which buys HYPE on the open market and burns it. That is more than $800M a year of buying, close to 5% of the traded market cap. Very little else in the market returns cash to holders this cleanly, and the buyback is visible on-chain rather than promised on a slide.
A rich price only works if the fees keep climbing. Everything here is an attempt to bound whether they can.
Revenue is going the wrong way
This is the headline the bull case tends to skip. Quarterly revenue peaked at $320M and has fallen for three straight quarters as the post-launch frenzy cooled and a rival, Aster, took share. The decline is real, though the last step looks like it is flattening.
Fig 1 · Quarterly revenue, down roughly 45% from the peak.
The dollars it chose not to capture
One notable giveaway. Hyperliquid dropped its own stablecoin, USDH, and now uses USDC as the primary collateral asset. Coinbase acquired the USDH brand in May 2026. The practical effect is that the interest on billions of dollars of trading collateral goes to Circle and Coinbase, not to HYPE holders. Defensible for product quality, since deep, trusted USDC liquidity is worth a lot, but it hands a large income stream to someone else. Hyperliquid monetizes the trading, not the dollars sitting still.
The team
Jeff Yan and a small, low-profile crew built the best-performing on-chain order book in the market, their own layer-1 chain, a smart-contract layer, and a system that lets anyone launch new markets. They did it with no venture capital and almost no marketing. Elite builders. The flip side is a small team you cannot see much of, which is its own kind of risk.
What has to happen, and how likely
The debate is really one question: is this a perp exchange whose revenue is falling, or a general-purpose blockchain that happens to print cash? The honest answer sits in between and depends on whether HyperEVM becomes a real ecosystem rather than a feature. The scenarios below are probability-weighted, and the expected value lands about 25% above spot, but note that almost all of that upside lives in the bull tail.
EXPECTED VALUE ≈ $82 · ~25% ABOVE ~$65 SPOT · CARRIED BY THE BULL TAIL
The buyback runs on-chain and is auditable. Roughly 97 to 99% of fees go to the Assistance Fund, which buys and burns HYPE.
Hyperliquid runs its own chain, so a precise largest-holder breakdown was not cleanly available this pass. The dilution risk is a range, not a fixed number.
Only ~26% of supply is out. Core-contributor unlocks (2027-28) plus a 38.8% emissions reserve are still to come. The "cheap" circulating price is on a small slice.
The call
Grade BBB. A core-quality holding, priced fairly to richly at the top of its range, with a shrinking core and a dilution clock ticking in the background. If you are bullish on crypto liquidity, this is one of the highest-quality names to own, sized to that view, and the HyperEVM optionality is the reason to hold through the cycle. If you are not, the disciplined entry is to wait for revenue to stop falling or for a real pullback off the high. The single thing to watch: does quarterly revenue stop declining, and do buybacks stay bigger than new token emissions. That, not the market-share headlines, decides whether the elite accrual actually compounds.
Confidence and what we could not verify
Moderate to high. The fee and revenue data is unusually clean and the buyback is on-chain and auditable. We could not cleanly pull the exact largest-holder breakdown on Hyperliquid's own chain, and the future emissions pace is discretionary, so the dilution risk is a range rather than a fixed number. Neither changes the picture: an elite business, an honest price rather than a bargain, and a dilution clock running quietly underneath.